Inversago Pharma Inc.: Inversago Pharma Announces Appointment of Ed Mathers, BSc and Nanna Lüneborg, PhD, MBA to its Board of Directors
Board appointments following recent $95 million CAD Series C Financing Inversago Pharma Inc. ("Inversago"), a clinical stage biotech company with a unique portfolio of peripherally-acting CB1 inverse
Source: finanznachrichten.de